Read more about ASCO News: Two New Drugs Show Promise for Recurrent Ovarian Cancer
Jun 4, 2014
ASCO News: Two New Drugs Show Promise for Recurrent Ovarian Cancer
...serous or was related to a BRCA gene mutation, or change, received either olaparib by itself or olaparib plus cediranib. Researchers found that 80% of the women who received the...